Adjuvant Gemcitabine Versus Neoadjuvant/Adjuvant FOLFIRINOX in Resectable Pancreatic Cancer: The Randomized Multicenter Phase II NEPAFOX Trial
Titel:
Adjuvant Gemcitabine Versus Neoadjuvant/Adjuvant FOLFIRINOX in Resectable Pancreatic Cancer: The Randomized Multicenter Phase II NEPAFOX Trial
Auteur:
Goetze, Thorsten O. Reichart, Alexander Bankstahl, Ulli S. Pauligk, Claudia Loose, Maria Kraus, Thomas W. Elshafei, Moustafa Bechstein, Wolf O. Trojan, Jörg Behrend, Matthias Homann, Nils Venerito, Marino Bohle, Wolfram Varvenne, Michael Bolling, Claus Behringer, Dirk M. Kratz-Albers, Karsten Siegler, Gabriele M. Hozaeel, Wael Al-Batran, Salah-Eddin